Products - Antigen - Growth Disorders - Growth Hormones

Growth Hormones

Contact our Antigen Product Team for further details and information

Disease information

Vitamin D has multiple derivatives and can be produced endogenously or received exogenously through diets and supplements?1 Total 25-hydroxyvitamin D((25(OH)D] and 1,25-Dihydroxy Vitamin D measurements (biologically active) are useful assessments of vitamin D sufficiency, chronic kidney disease secondary hyperparathyroidism and sarcoidosis.1,2,3

Diagnostic Guidelines

Growth disorders can have a genetic or environmental cause or be a consequence of chronic diseases such as Crohn’s or coeliac disease. In rare cases, psychosocial or diet-related causes or hormone disorders are responsible for growth disorders. Finding the underlying cause is therefore the primary focus of growth disorder diagnostics.

The growth hormone (GH) of the pituitary gland and thyroid hormones are crucial for the regulation of growth. In the case of hormonal short stature, one or several of the hormones necessary for growth are not or insufficiently produced. This deficiency can have a congenital cause or one acquired during childhood. In contrast to other forms of short stature, growth hormone deficiency is treatable.1

Endocrine-related tall stature is caused by hypersecretion of insulin-like growth factor I (IGF-I). In children and adolescents this hormone excess often causes changes of appearance, manifesting as excessively tall stature (so-called gigantism), while in adults it often leads to growth of certain parts of the body, so-called acromegaly. The IGF-I concentration can be determined to diagnose growth disorders rapidly and to monitor growth hormone treatment.2

Growth Hormone ChLIA markers

For In Vitro Diagnostic Use.

wdt_ID Method Parameter Sample Part Number Control Calibrator
638 ChLIA Human growth hormone (hGH)

Serum, plasma
IS-3700

Included
639 ChLIA Insulin like growth factor (IGF-1)
Serum, plasma IS-3900 IS-3930 Included
640 ChLIA Insuline like growth factor binding protein 3 (IGFBP-3) Serum, plasma
IS-4400 IS-4430 Included

References

1. Grimberg A, Allen DB. Growth hormone treatment for growth hormone deficiency and idiopathic short stature: new guidelines shaped by the presence and absence of evidence. Curr Opin Pediatr. 2017 Aug;29(4):466-471.
2. Fleseriu M, Biller BMK, Freda PU, Gadelha MR, Giustina A, Katznelson L, Molitch ME, Samson SL, Strasburger CJ, van der Lely AJ, Melmed S. A Pituitary Society update to acromegaly management guidelines. Pituitary. 2021 Feb;24(1):1-13.

Contact our Antigen Product Team for further details and information

2025 Euroimmun US

Privacy Policy | Website Terms and Conditions | Cookie Notice and Settings | Consent Preferences | Sitemap